FDMT icon

4D Molecular Therapeutics
FDMT

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$30
281% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Geulah Livshits
50% 1-yr FDMT win rate
18 Dec ‘25 1 month ago
RBC Capital
RBC Capital
Lisa Walter
0% 1-yr FDMT win rate
11 Nov ‘25 2 months ago
Barclays
Barclays
Gena Wang
50% 1-yr FDMT win rate
11 Nov ‘25 2 months ago